Public Workshop on the Clinical Development of Drugs to Prevent Infections Caused by Staphylococcus Aureus in the Healthcare Setting

The Food and Drug Administration (FDA) is announcing a public workshop entitled “Clinical Development of Drugs for the Prevention of Infections Caused by Staphylococcus aureus in the Health Care Setting.” The workshop will focus on the clinical development of drugs for the prevention of serious infections caused by Staphylococcus aureus in the health care setting.

Public workshops are intended to provide information for and gain perspective from health care providers, researchers, academia, and industry on various aspects of the scientific issues, technical issues, and/or the design and conduct of clinical trials. The input from this public workshop will help in developing topics for further discussion on the topic mentioned above.


September 5, 2014


8:30am to 3:00pm


The DoubleTree by Hilton Hotel
8727/8728 Colesville Road
Silver Spring, MD   20910


Registration is free and interested parties are encouraged to register early.  Electronic registration is encouraged and information (name, title, firm name, address, telephone and fax number) should be sent to fdastaphworkshop@fda.hhs.gov. Onsite registration will be available on the day of the workshop, but advance registration is preferred. Persons unable to register electronically can call 301-796-1300 to register.


Page Last Updated: 09/25/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English